Paper4698338
Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
McCrory WW and 3 others. J Pediatr, 1973. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. Papers, record 4698338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4698338
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Nephrotic Syndrome | Major topic |
| Prednisolone | Major topic |
| Adolescent | |
| Alopecia | |
| Child | |
| Child, Preschool | |
| Digestive System | |
| Dose-Response Relationship, Drug | |
| Drug Synergism | |
| Humans | |
| Leukopenia | |
| Lymphopenia | |
| Proteinuria | |
| Recurrence | |
| Remission, Spontaneous | |
| Urogenital System |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39513526 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/39513526 | PubMed |
| 32297308 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32297308 | PubMed |
| 25785660 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/25785660 | PubMed |
| 18324421 | Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome. | Pediatr Nephrol | 2008 | https://conductscience.org/library/papers/18324421 | PubMed |
| 4425844 | Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. | Br Med J | 1974 | https://conductscience.org/library/papers/4425844 | PubMed |
| 3740921 | Minimal change nephrotic syndrome and cyclophosphamide. | Arch Dis Child | 1986 | https://conductscience.org/library/papers/3740921 | PubMed |
| 3391218 | Cyclophosphamide in treatment of minimal change nephrotic syndrome. | Eur J Pediatr | 1988 | https://conductscience.org/library/papers/3391218 | PubMed |
| 2248508 | Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. | Arch Dis Child | 1990 | https://conductscience.org/library/papers/2248508 | PubMed |
| 1278059 | Clinical use of immunosuppressive drugs: part II. | Drugs | 1976 | https://conductscience.org/library/papers/1278059 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4698338
GET https://conductscience.org/api/papers/v1/4698338/authors